Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro

BACKGROUND: Everolimus (EVE), a mammalian target of rapamycin inhibitor, has been proposed as liver transplant immunosuppressive drug, gaining wide interest also for the treatment of cancer. Although an appropriate tolerance, it may induce several adverse effects, such as fibro-interstitial pneumoni...

詳細記述

保存先:
書誌詳細
出版年:BMC Gastroenterol
主要な著者: Masola, Valentina, Carraro, Amedeo, Zaza, Gianluigi, Bellin, Gloria, Montin, Umberto, Violi, Paola, Lupo, Antonio, Tedeschi, Umberto
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2015
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570634/
https://ncbi.nlm.nih.gov/pubmed/26369804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-015-0347-6
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料